paper? I watched and am still confused. Who loses in this deal? It might be bad news for AmerisourceBergen and Cardinal Health���the two other biggest providers of infused cancer drugs, according to Jefferies. Both will no longer have the opportunity to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Why Did McKesson Buy U.S. Oncology?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account